| 1 |
9 Meters Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 2 |
Acer Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 3 |
Actavia Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 4 |
Active Fine Chemicals Ltd (Bangladesh) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 5 |
Adhera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 6 |
Aktsnrny Krgnsky bshchstv Mdtsnskkh (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 7 |
Albert Labs International Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 8 |
AliveDx Suisse S.A. (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 9 |
American Bio Medica Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 10 |
Apollon Formularies PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 11 |
Applied Molecular Transport Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 12 |
Athersys Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 13 |
Ayala Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 14 |
BELLUS Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 15 |
Bharat Immunologicals&Biologcls Corp Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 16 |
Biosintez PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 17 |
Boehringer Ingelheim GmbH (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 18 |
Braxia Scientific Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 19 |
Calithera Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 20 |
CH Boehringer Sohn AG & Co KG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 21 |
Chembio Diagnostics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 22 |
China Health Industries Holdings, Inc. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 23 |
CMIC Holdings Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 24 |
Colabs Int'l Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 25 |
ContraFect Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 26 |
CTI BioPharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 27 |
Dal'khimfarm OAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 28 |
Deciphera Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 29 |
DMK Pharmaceuticals Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 30 |
Elysium Pharmaceuticals Ltd. (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 31 |
Endo International PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 32 |
Eom Pharmaceutical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 33 |
EQRx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 34 |
Farmak AT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 35 |
Farmsintez PAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 36 |
Farmstandart-Tomskkhimfarm OAO (P) (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 37 |
FUREN Group Pharmaceutical Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 38 |
Gelesis Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 39 |
Genocea Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 40 |
Glaxo Smithkline Consumer Nigeria PLC (Nigeria) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 41 |
GlobeStar Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 42 |
Haemato AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 43 |
Horizon Therapeutics PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 44 |
ImmunoGen, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 45 |
Infinity Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 46 |
Innovation Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 47 |
IntelGenx Technologies Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 48 |
Intellipharmaceutics International Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 49 |
Jadran Galenski Laboratorij dd (Croatia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 50 |
JFL Life Sciences Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 51 |
Jilin Zixin Pharmaceutical Ind. Co., Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 52 |
KaiBioTech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 53 |
Karo Healthcare AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 54 |
Kolinpharma SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 55 |
Kyivmedpreparat AT (Ukraine) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 56 |
Labomar SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 57 |
Lansen Pharmaceutical Holdings Limited (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 58 |
LFB S.A. (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2016 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 59 |
Lucy Scientific Discovery Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 60 |
Med X Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 61 |
Melodiol Global Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 62 |
Mercury Pharma Group Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 63 |
Merrimack Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 64 |
Mindset Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 65 |
Mithra Pharmaceuticals SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 66 |
Neubase Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 67 |
NeutriSci International Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 68 |
Nichi-iko Pharmaceutical Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 69 |
North Sur Resources Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 70 |
Odonate Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 71 |
Origin Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 72 |
Paion AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 73 |
Panacea Life Sciences Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 74 |
Parenteral Drugs (India) Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 75 |
Pcas SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 76 |
Petro Usa Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 77 |
Pharmacare PLC (Palestinian territories) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 78 |
Pharnext SCA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 79 |
Pierrel S.p.A. (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 80 |
Probiotec Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 81 |
Procaps Group SA (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 82 |
Q BioMed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/28/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 83 |
Reata Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 84 |
Rebus Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 85 |
Redwood Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 86 |
RegeneRx Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 87 |
Respirerx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 88 |
Reunion Neuroscience, Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 89 |
RLS Global AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 90 |
Sangui Biotech International Inc (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 91 |
Satsuma Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 92 |
Selectimmune Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 93 |
Sharon Bio-Medicine Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 94 |
Sigilon Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 95 |
Sinclair Pharma Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 96 |
Sio Gene Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 97 |
Spectrum Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 98 |
Squarex Pharmaceutical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 99 |
Sunwin Stevia International Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 100 |
TAISHO PHARMACEUTICAL HOLDINGS Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 101 |
Taro Pharmaceutical Industries Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 102 |
Theradiag SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 103 |
Thorne HealthTech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 104 |
TV Pharm Pharmaceutical JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 105 |
Vilin Bio Med Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |